To date, research pertaining to reactive lymphadenopathy has focused mostly on patients with cancer who are routinely staged and monitored via PET/CT or in women undergoing breast cancer screening and/or imaging with mammography and ultrasound.

Burnout is a growing problem across the healthcare industry, and physicians are feeling symptoms worse than ever as the COVID-19 pandemic stretches on.

The Cardiovascular Research Foundation (CRF) announced the 32 late-breaking studies being presented at the Transcatheter Cardiovascular Therapeutics 2022 annual meeting at in Boston, Sept. 16-19.

Progestin-only products may be a "safer alternative" for this patient population, according to a new analysis. 

Researchers examined data from nearly 31,000 adult patients hospitalized with COVID-19, sharing their findings in Circulation: Arrhythmia and Electrophysiology.

“This procedure potentially solves the problem of a growing valve,” the lead surgeon said. “If we can eliminate the need for multiple open-heart surgeries every time a child outgrows an old valve, we could be extending the life of that child by potentially decades or more.”

Erin D. Michos, MD, co-editor in chief of the American Journal of Preventive Cardiology, discusses gender differences in heart disease presentations.

Briefly trained in point-of-care cardiac ultrasound, 72% of second-year medical students obtained clinical-quality views from a mannequin and 61% made the correct diagnosis in a volunteer simulated patient.